Indiana Senate Bill 492 (Prior Session Legislation)

---

Spectrum: Partisan Bill (Republican 1-0)
Status: Introduced on January 13 2011 - 25% progression, died in committee
Action: 2011-01-13 - First reading: referred to Committee on Health and Provider Services
Pending: Senate Health and Provider Services Committee
Text: Latest bill text (Introduced) [HTML]

Requires the drug utilization review board (board) to develop, implement, and maintain a generically equivalent drug product Medicaid reimbursement program (program). Requires the manufacturer of a generically equivalent drug product to submit the cost that it would offer to a Medicaid provider for its drug in order to participate in the Medicaid program, and specifies that the cost may not exceed the maximum allowable rate determined by the office of Medicaid policy and planning. Requires the board to review the submissions and determine a Medicaid reimbursement rate for the therapeutic drug classification. Requires the office of Medicaid policy and planning to reimburse Medicaid providers at the rate determined by the board for the therapeutic drug classification. Establishes a time line for the implementation of the program for certain therapeutic drug classifications.

Medicaid generic drug reimbursement program.

Sen. Beverly Gard [R]

Date	Chamber	Action
2011-01-13		First reading: referred to Committee on Health and Provider Services
2011-01-13		Authored by Senator Gard

Type	Source
Summary	http://www.in.gov/apps/lsa/session/billwatch/billinfo?year=2011&session=1&request=getBill&doctype=SB&docno=0492
Text	http://www.in.gov/legislative/bills/2011/IN/IN0492.1.html